Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Xinyi Xia and Lingxiang Wu.
Xinyi Xia
Connection Strength
0.748
Lingxiang Wu
  1. Dynamic changes in anti-SARS-CoV-2 antibodies during SARS-CoV-2 infection and recovery from COVID-19. Nat Commun. 2020 11 27; 11(1):6044.
    View in: PubMed
    Score: 0.229
  2. Improved clinical symptoms and mortality among patients with severe or critical COVID-19 after convalescent plasma transfusion. Blood. 2020 08 06; 136(6):755-759.
    View in: PubMed
    Score: 0.224
  3. Comparative Characterization and Risk Stratification of Asymptomatic and Presymptomatic Patients With COVID-19. Front Immunol. 2021; 12:700449.
    View in: PubMed
    Score: 0.060
  4. Sex-based clinical and immunological differences in COVID-19. BMC Infect Dis. 2021 Jul 05; 21(1):647.
    View in: PubMed
    Score: 0.060
  5. High Expression of ACE2 and TMPRSS2 at the Resection Margin Makes Lung Cancer Survivors Susceptible to SARS-CoV-2 With Unfavorable Prognosis. Front Oncol. 2021; 11:644575.
    View in: PubMed
    Score: 0.059
  6. Implications of cardiac markers in risk-stratification and management for COVID-19 patients. Crit Care. 2021 04 26; 25(1):158.
    View in: PubMed
    Score: 0.059
  7. Implications of liver injury in risk-stratification and management of patients with COVID-19. Hepatol Int. 2021 Feb; 15(1):202-212.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.